AI Article Synopsis

  • Multiple sclerosis (MS) is an autoimmune disorder affecting the central nervous system, primarily driven by harmful Th17 cells that produce inflammatory signals.
  • Research indicates that let-7 miRNAs can protect against MS by inhibiting the growth and movement of these damaging Th17 cells into the central nervous system.
  • This study highlights the potential of let-7 miRNAs as a therapeutic target for treating conditions related to MS by regulating Th17 cell differentiation.

Article Abstract

Multiple sclerosis (MS) is a disabling demyelinating autoimmune disorder of the central nervous system (CNS) which is driven by IL-23- and IL-1β-induced autoreactive Th17 cells that traffic to the CNS and secrete proinflammatory cytokines. Th17 pathogenicity in MS has been correlated with the dysregulation of microRNA (miRNA) expression, and specific miRNAs have been shown to promote the pathogenic Th17 phenotype. In the present study, we demonstrate, using the animal model of MS, experimental autoimmune encephalomyelitis (EAE), that let-7 miRNAs confer protection against EAE by negatively regulating the proliferation, differentiation and chemokine-mediated migration of pathogenic Th17 cells to the CNS. Specifically, we found that let-7 miRNAs may directly target the cytokine receptors and , as well as the chemokine receptors and . Therefore, our results identify a novel regulatory role for let-7 miRNAs in pathogenic Th17 differentiation during EAE development, suggesting a promising therapeutic application for disease treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978752PMC
http://dx.doi.org/10.3389/fimmu.2019.03125DOI Listing

Publication Analysis

Top Keywords

pathogenic th17
16
th17 cells
12
let-7 mirnas
12
multiple sclerosis
8
th17
6
differentiation pathogenic
4
cells negatively
4
negatively regulated
4
let-7
4
regulated let-7
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!